LegoChemBio Signs License Agreement to Acquire First-in-class Antibody From Elthera DAEJEON, South Korea--(BUSINESS WIRE)--LegoChem Biosciences Inc. (KOSDAQ:141080) (hereinafter “LegoChemBio”) announced on February 13, 2023 a license agreement with Elthera AG, a biotechnology company in Switzerland, to develop and commercialize a novel antibody-drug conjugate (ADC) therapy using a monoclonal antibody developed by [...]

Consortium of industrial and academic partners led by Elthera receives Eurostars grant SCHLIEREN, SCHWEIZ, November 10, 2020 /EINPresswire.com/ -- Elthera AG, iCellate Medical AB, Targos GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that [...]

Elthera Awarded 2.5 M € Grant From Horizon 2020 Program ZURICH, June 17, 2019 /PRNewswire/ -- Elthera is pleased to announce that it has been awarded 2.5 M € through the Horizon 2020 programme. Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative, [...]